Sort   by:  
 Page size 
UnknownCobicistat-boosted darunavir in HIV-1-infected adults: week 48 results of a Phase IIIb, open-label single-arm trial.
Not available
S-EPMC4413526 | biostudies-literature
UnknownExpansion of highly cytotoxic human natural killer cells for cancer cell therapy.
Not available
S-EPMC2716664 | biostudies-literature
UnknownPeginterferon-alpha-2a add-on to treatment with siRNA JNJ-73763989 in virologically suppressed chronic hepatitis B: The phase II PENGUIN study.
Not available
S-EPMC12409438 | biostudies-literature
UnknownSafety, tolerability, and pharmacokinetics of AL-335 in healthy volunteers and hepatitis C virus-infected subjects.
Not available
S-EPMC6191080 | biostudies-literature
UnknownSafety, antiviral activity and pharmacokinetics of JNJ-64530440, a novel capsid assembly modulator, as 4 week monotherapy in treatment-naive patients with chronic hepatitis B virus infection.
Not available
S-EPMC8969529 | biostudies-literature
UnknownDaily Mosnodenvir as Dengue Prophylaxis in a Controlled Human Infection Model.
Not available
S-EPMC12662413 | biostudies-literature
Sort   by:  
 Page size